ALZAMEND NEURO INC ALZN
COM NEW 2025 · Common Stock · CUSIP 02262M605
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersAtlanta, GA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.20.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2025 | 8 |
| Q3 2025 | 12 |
| Q4 2025 | 13 |
| Q1 2026 | 13 |
| Q2 2026 | 12 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2025 | 8 | 2 |
| Q4 2025 | 8 | 2 |
| Q1 2026 | 4 | 5 |
| Q2 2026 | 4 | 7 |
Biggest buyers
| KMT WEALTH MANAGEMENT, LLC | New | +1.3m |
| Kingsbury Capital Investment Advisors LLC | Added | +762.4k |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | +3.2k |
| IFG Advisory, LLC | New | +22 |
Biggest sellers
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -19.3k |
| MORGAN STANLEY | Sold out | -18.0k |
| Clearstead Advisors, LLC | Sold out | -10.0k |
| CITIGROUP INC | Sold out | -5.2k |
| Tower Research Capital LLC (TRC) | Reduced | -2.7k |
| UBS Group AG | Reduced | -2.2k |
| Caitong International Asset Management Co., Ltd | Reduced | -1 |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 3 | $25.9k | 0 | — | — |
| Q2 2025 | 0 | — | 1 | $6.2k | — |
| Q3 2025 | 0 | — | 1 | $1.3m | — |
| Q4 2025 | 0 | — | 3 | $946.2k | — |
| Q1 2026 | 0 | — | 0 | — | — |
| Q2 2026 | 1 | $110.4k | 0 | — | — |
| Q3 2026 | 0 | — | 1 | $3.1k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2026-08-26 | AULT MILTON C III Director | Sold | $3.1k2.0k shares |
| 2026-04-14 | AULT MILTON C III Director · By Ault Lending, LLC | Bought | $108.4k108.4k shares |
| 2026-04-14 | AULT MILTON C III Director | Bought | $2.1k2.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Kingsbury Capital Investment Advisors LLC 1.35% of their portfolio | 1.3m $1.6m | Added +762.4k |
| KMT WEALTH MANAGEMENT, LLC 1.35% of their portfolio | 1.3m $1.6m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 26.4k $31.6k | Reduced -19.3k |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 21.0k $25.2k | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 7.6k $9.1k | Added +3.2k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.5k $4.2k | Reduced -2.7k |
| UBS Group AG 0.00% of their portfolio | 2.4k $2.8k | Reduced -2.2k |
| BlackRock, Inc. 0.00% of their portfolio | 437 $524 | Unchanged |
| IFG Advisory, LLC 0.00% of their portfolio | 22 $26 | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 22 $26 | Unchanged |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 3 $4 | Reduced -1 |
| HARBOR INVESTMENT ADVISORY, LLC 0.00% of their portfolio | 1 $1 | Unchanged |